# Boston Scientific Invests $1.5B in MiRus with Option to Acquire Its TAVR Business

> ma · REPORTED · 2026-07-01

Boston Scientific announced a $1.5 billion strategic investment in MiRus that includes an option to acquire MiRus's transcatheter aortic valve replacement (TAVR) business. The deal signals Boston Scientific's intent to further expand its structural heart and cardiovascular device portfolio.

About Boston Scientific: Boston Scientific is a global medical device company that develops minimally invasive products across interventional cardiology, electrophysiology, structural heart, endoscopy, and other specialty areas.

- Company: Boston Scientific
- Sector: cardiology
- Primary source: https://cardiovascularbusiness.com/topics/healthcare-management/healthcare-economics/atraverse-medical-raises-29m-support-fda-approved-heart-tech

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.